Tesla, Oracle, Novavax, DraftKings, Pfizer: Why These Five Stocks Are Trending Today

U.S. stocks showcased a positive momentum as the trading day approached its end. The Nasdaq Composite exhibited a notable rise, gaining more than 1% on Monday. The tech-heavy index closed at 13,917.89 for the day.

The Dow Jones Industrial Average also reflected an upward trend, increasing by 0.25% to reach 34,663.72. Similarly, the S&P 500 index followed suit, marking a 0.67% rise to settle at 4,487.46.

These are the top stocks that gained the attention of retail traders and investors throughout the day:

Oracle Corporation ORCL
Oracle’s stock performance for the day saw a slight increase of 0.31%, closing at $126.71. The stock reached an intraday high of $127.42 and a low of $124.72. Its 52-week range spans from $60.78 to $127.54. Oracle reported a first-quarter revenue of $12.45 billion, marking a 9% year-over-year growth. The company’s cloud revenue, which totaled $4.6 billion, saw a significant 30% increase from the previous year. Larry Ellison, Oracle’s Chairman and CTO, emphasized the potential of Generative AI, hinting at its transformative capabilities.

Tesla, Inc. TSLA
Tesla’s stock surged by a remarkable 10.09%, closing at $273.58. The stock peaked at an intraday high of $274.85 and dipped to a low of $260.61. Its 52-week range is between $101.81 and $313.8. Morgan Stanley analyst Adam Jonas recently highlighted Tesla’s custom supercomputer, Dojo, as a potential game-changer, predicting it could significantly boost the Elon Musk-led company’s enterprise value.

Novavax, Inc. NVAX
Novavax experienced a decline of 12.88%, with its stock closing at $7.82. The stock’s intraday high and low were $9.02 and $7.73, respectively, and its 52-week range is between $5.61 and $33.37. While Moderna and Pfizer received FDA approval for their updated COVID-19 vaccines, Novavax, which uses protein-based technology, is still awaiting a nod from the FDA.

DraftKings Inc. DKNG
DraftKings’ stock saw a minor dip of 0.19%, closing at $31.79. The stock’s intraday high was $32.65, and its low was $31.52. Over the past 52 weeks, the stock has ranged from $10.69 to $34.49. DraftKings recently faced criticism for a “Never Forget” parlay promotion, which they later apologized for, emphasizing their respect for the significance of 9/11.

Pfizer Inc. PFE
Pfizer’s stock declined by 0.91%, closing at $33.94. The stock’s intraday high and low were $34.3 and $33.54, respectively, with a 52-week range between $33.54 and $54.93. Recent data indicates that Pfizer’s short percent of float has risen, suggesting a shift in market sentiment towards the stock.

Photo by Phongphan on Shutterstock

Prepare for the day's trading with top premarket movers and news by Benzinga.